Business
BioMarin Appoints Arpit Davé Chief Digital and Information Officer
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced it has appointed Arpit Davé as Executive Vice President, Chief Digital and Information Officer, a new position reporting directly to President and Chief Executive Officer Alexander Hardy. Mr. Davé will be responsible for reimagining and executing BioMarin's enterprise technology strategy, data science and digital transformation to help create value for patients, employees and shareholders. He joins BioMarin today and will serve on the B
About this update from Biomarin Pharmaceutical Inc.
[{"type":"text","content":"Mr. Davé Brings more than 20 Years of Experience in Creating Enterprise Value through Digital Transformation, Information Technology and Artificial Intelligence across the Biopharmaceutical Industry","length":198,"tagName":"p","attribs":{}},{"type":"text","content":"SAN RAFAEL, Calif., Jan. 12, 2026 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced it has appointed Arpit Davé as Executive Vice President, Chief Digital and Information Officer, a new position reporting directly to President and Chief Executive Officer Alexander Hardy. Mr. Davé will be responsible for reimagining and executing BioMarin's enterprise technology strategy, data science and digital transformation to help create value for patients, employees and shareholders. He joins BioMarin today and will serve on the BioMarin Leadership Team.","length":578,"tagName":"p"},{"type":"image","alt":"BioMarin Pharmaceutical logo (PRNewsfoto/BioMarin Pharmaceutical Inc.)","displaySize":"","headline":null,"caption":"BioMarin Pharmaceutical logo (PRNewsfoto/BioMarin Pharmaceutical Inc.)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":59,"url":"https://media.zenfs.com/en/prnewswire.com/db94610f2d68c7fd655942d2889db5d2"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/KxRqzB62ez2RdMQaPUuMVg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTEwNDtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/db94610f2d68c7fd655942d2889db5d2","width":400,"height":59}},"href":"https://mma.prnewswire.com/media/534018/BioMarin_Pharmaceutical_Inc_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Mr. Davé is a proven leader who brings to the role more than 20 years of experience in information technology and artificial intelligence (AI) in the biopharmaceutical industry. He has a strong track record of driving patient-focused organizations to deliver measurable business growth and profitability. Mr. Davé joins BioMarin from Amgen, Inc., where he has served as a technology executive for the past seven and a half years. In his most recent roles, he was responsible for the teams driving digital transformation through artificial intelligence and digital technology and innovation, focused on evolving the company to be competitive in the rapidly changing era of AI. Prior to Amgen, he held leadership roles at Bristol Myers ...